Lamivudine as a Novel Clinical Effort for Rett Syndrome
Lamivudine as a Novel Clinical Effort for Rett Syndrome
Enrolling by invitation · NCT07640503 · Registry updated 2026-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lamivudine as a Novel Clinical Effort for Rett Syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Rett syndrome, X-linked disease, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorder | Enrolling by invitation | Phase 2 | 2026-06-10 | NCT07640503 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Maria Denise Fernandes Carvalho de Andrade | 1 |
| University of California, San Diego | 337 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| GenClinics | Fortaleza | Brazil | 1 |